0001127602-21-007295.txt : 20210223
0001127602-21-007295.hdr.sgml : 20210223
20210223162502
ACCESSION NUMBER: 0001127602-21-007295
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210219
FILED AS OF DATE: 20210223
DATE AS OF CHANGE: 20210223
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Babu Yarlagadda S
CENTRAL INDEX KEY: 0001452635
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-23186
FILM NUMBER: 21665850
MAIL ADDRESS:
STREET 1: 2190 PARKWAY LAKE DR
CITY: BIRMINGHAM
STATE: AL
ZIP: 35244
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOCRYST PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000882796
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 621413174
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4505 EMPEROR BOULEVARD
STREET 2: SUITE 200
CITY: DURHAM
STATE: NC
ZIP: 27703
BUSINESS PHONE: 919-859-1302
MAIL ADDRESS:
STREET 1: 4505 EMPEROR BOULEVARD
STREET 2: SUITE 200
CITY: DURHAM
STATE: NC
ZIP: 27703
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2021-02-19
0000882796
BIOCRYST PHARMACEUTICALS INC
BCRX
0001452635
Babu Yarlagadda S
4505 EMPEROR BLVD.
SUITE 200
DURHAM
NC
27703
1
Senior VP - Drug Discovery
Common Stock
2021-02-19
4
M
0
50000
4.15
A
205587
D
Common Stock
2021-02-19
4
F
0
22431
11.53
D
183156
D
Stock Option (Right to Buy)
4.15
2021-02-19
4
M
0
50000
0
D
2012-03-01
2021-03-01
Common Stock
50000
0
D
Shares of Common Stock delivered to the Company to satisfy payment of exercise price and tax withholding in connection with stock option exercise.
/s/ Alane P. Barnes, by power of attorney
2021-02-23